Evidence map›Paper›PMID 40004088›Full record

ArticleInternational journal of molecular sciences2025

GCN2-Mediated eIF2α Phosphorylation Is Required for Central Nervous System Remyelination.

Paulina Falcón, Álvaro Brito, Marcela Escandón, Juan Francisco Roa, Nicolas W Martínez, Ariel Tapia-Godoy, Pamela Farfán, Soledad Matus

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paulina FalcónFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.
Álvaro BritoFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.
Marcela EscandónFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.ORCID 0000-0003-2557-6332
Juan Francisco RoaFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.ORCID 0009-0001-0266-1027
Nicolas W MartínezFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.ORCID 0000-0001-5559-9952
Ariel Tapia-GodoyFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.
Pamela FarfánFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.
Soledad MatusFundación Ciencia & Vida, Avenida del Valle 725, Huechuraba, Santiago 8580704, Chile.ORCID 0000-0002-5284-151X

Funding

Agencia Nacional de Investigación y Desarrollo 1230334Agencia Nacional de Investigación y Desarrollo 15150012Agencia Nacional de Investigación y Desarrollo 3180189Agencia Nacional de Investigación y Desarrollo 3200932Agencia Nacional de Investigación y Desarrollo FB210008
6 · The paper itself

Abstract

Under conditions of amino acid deficiency, mammalian cells activate a nutrient-sensing kinase known as general control nonderepressible 2 (GCN2). The activation of GCN2 results in the phosphorylation of the alpha subunit of the eukaryotic initiation factor 2 (eIF2α), which can be phosphorylated by three other three integrated stress response (ISR) kinases, reducing overall protein synthesis. GCN2 activation also promotes the translation of specific mRNAs, some of which encode transcription factors that enhance the transcription of genes involved in the synthesis, transport, and metabolism of amino acids to restore cellular homeostasis. The phosphorylation of eIF2α has been shown to protect oligodendrocytes, the cells responsible for producing myelin in the central nervous system during remyelination. Here, we explore the potential role of the kinase GCN2 in the myelination process. We challenged mice deficient in the GCN2-encoding gene with a pharmacological demyelinating stimulus (cuprizone) and evaluated the recovery of myelin as well as ISR activation through the levels of eIF2α phosphorylation. Our findings indicate that GCN2 controls the establishment of myelin by fine-tuning its abundance and morphology in the central nervous system. We also found that GCN2 is essential for remyelination. Surprisingly, we discovered that GCN2 is necessary to maintain eIF2α levels during remyelination.

Indexed as

Central Nervous SystemEukaryotic Initiation Factor-2Myelin SheathProtein Serine-Threonine KinasesRemyelinationAnimalsDemyelinating DiseasesMiceMice, Inbred C57BLMice, KnockoutOligodendrogliaPhosphorylationEif2ak4 protein, mouseEukaryotic Initiation Factor-2Protein Serine-Threonine KinasescuprizoneeIF2αGCN2ISRmyelinremyelination

Identifiers

PMID40004088
PMCPMC11855834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.